Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit

Archives of Internal Medicine

Volumn 163, Issue 16, 2003, Pages 1905-1912

  Martinez, José A ^a   Ruthazer, Robin ^c   Hansjosten, Karen ^c   Barefoot, Laurie ^c   Snydman, David R ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b TUFTS MEDICAL CENTER   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTACID AGENT; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFOXITIN; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOSPORIN; MACROLIDE; METRONIDAZOLE; OMEPRAZOLE; OXACILLIN; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; SUCRALFATE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BACTERIUM ISOLATE; CASE CONTROL STUDY; CLEANING; CONTROLLED STUDY; ENTERIC FEEDING; ENTEROCOCCUS; ENVIRONMENTAL FACTOR; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RANDOMIZATION; RETROSPECTIVE STUDY; RISK FACTOR; VANCOMYCIN RESISTANT ENTEROCOCCUS;

AGED; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; CROSS INFECTION; ENTEROCOCCUS FAECIUM; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 0042835788     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.163.16.1905     Document Type: Article

References (56)

1. Murray BE. Vancomycin-resistant enterococcal infections. N Engl J Med. 2000;342:710-721.
2. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control. 1999;27:520-532.
3. Mayhall CG. The epidemiology and control of VRE: still struggling to come of age. Infect Control Hosp Epidemiol. 1999;20:650-652.
4. Thal LA, Chow JW, Mahayni R, et al. Characterization of antimicrobial resistance in enterococci J of animal origin. Antimicrob Agents Chemother. 1995;39:2112-2115.
5. Coque TM, Tomayko JF, Ricke SC, Okhyusen PC, Murray BE. Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States. Antimicrob Agents Chemother. 1996;40:2605-2609.
6. Silverman J, Thal LA, Perri MB, Bostic G, Zervos MJ. Epidemiologic evaluation of antimicrobial resistance in community-acquired enterococci. J Clin Microbiol. 1998;36:830-832.
7. Dhawan VK, Nachum R, Bhat N, Tolbert L, Agrawal M. Vancomycin-resistant enterococcal colonization in nonhospitalized HIV-infected patients. West J Med. 1998;169:276-279.
8. French GL. Enterococci and vancomycin resistance. Clin Infect Dis. 1998;27 (supp 1):S75-S83.
9. Montecalvo MA, de Lencastre H, Carraher M, et al. Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol. 1995;16:680-685.
10. Austin DJ, Bonten MJM, Weinstein RA, Slaughter S, Anderson RM. Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs. Proc NatlAcad Sci U S A. 1999;96:6908-6913.
11. Rubin LG, Tucci V, Cercenado E, Eliopoulos G, Isenberg HD. Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol. 1992;13:700-705.
12. Boyle JF, Soumakis SA, Rendo A, et al. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol. 1993;31:1280-1285.
13. Handwerger S, Raucher B, Altarac D, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis. 1993;16:750-755.
14. Boyce JM, Opal SM, Chow JW, et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994;32:1148-1153.
15. Montecalvo MA, Horowitz H, Gedris C, et al. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother. 1994;38:1363-1367.
16. Edmond MB, Ober JF, Weinbaum DL, et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors, for infection: Clin Infect Dis. 1995;20:1126-1133.
17. Moreno F, Grota P, Crisp C, et al. Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in Southern Texas. Clin Infect Dis. 1995;21:1234-1237.
18. Morris JG, Shay DK, Hebden JN, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin: establishment of endemicity in a university medical center. Ann Intern Med. 1995;123:250-259
19. Shay DK, Maloney SA, Montecalvo M, et al. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis. 1995;172:993-1000.
20. Gordts B, van Landuyt H, leven M, Vandamme P, Goossens H. Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalized patients. J Clin Microbiol. 1995;33:2842-2846.
21. Dembry LM, Uzokwe K, Zervos MJ. Control of endemic glycopeptide-resistant enterococci. Infect Control Hosp Epidemiol. 1996;17:286-292.
22. Henning KJ, Delencastre H, Eagan J, et al. Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection. Pediatr Infect Dis J. 1996;15:848-854.
23. Slaughter S, Hayden MK, Nathan C, et al. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med. 1996;125:448-456.
24. Papanicolaou GA, Meyers BR, Meyers J, et al. Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality. Clin Infect Dis. 1996;23:760-766.
25. Tornieporth NG, Roberts RB, John J, Hafner A, Riley LW. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin Infect Dis. 1996;23:767-772.
26. Bonten MJM, Hayden MK, Nathan C, et al. Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet. 1996;348:1615-1619.
27. Pegues DA, Pegues CF, Hibberd PL, Ford DS, Hooper DC. Emergence and dissemination of a highly vancomycin-resistant vana strain of Enterococcus faecium at a large teaching hospital. J Clin MicrobioL 1997;35:1565-1570.
28. Mainous MR, Lipsett PA, O'Brien M. Enterococcal bacteremia in the surgical intensive care unit: does vancomycin resistance affect mortality? Arch Surg. 1997;132:76-81.
29. Roghmann MC, McCarter RJ, Brewrink J, Cross AS, Morris JG. Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemia . Clin Infect Dis. 1997;25:1056-1059.
30. Stosor V, Peterson LR, Postelnick M, Noskin GA. Enterococcus faecium bacteremia: does vancomycin resistance make a difference? Arch Intern Med. 1998;158:522-527.
31. Bonten MJM, Slaughter S, Hayden MK, Nathan C, van Voorhis J, Weinstein RA. External sources of vancomycin-resistant enterococci for intensive care units. Crit Care Med. 1998;26:2001-2004.
32. Bonten MJM, Slaughter S, Ambergen AW, et al. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci. Arch Intern Med. 1998;158:1127-1132.
33. Fridkin SK, Yokoe DS, Whitney CG, Onderdonk A, Hooper DC. Epidemiology of a dominant clonal strain of vancomycin-resistant Enterococcus faecium at separate hospitals in Boston, Massachusetts. J Clin Microbiol 1998;36:965-970.
34. Lucas GM, Lechtzin N, Puryear W, Yau LL, Flexner CW, Moore RD. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. Clin Infect Dis. 1998;26:1127-1133.
35. Ostrowsky BE, Venkataraman L, D'Agata EMC, Gold HS, DeGirolami PC, Samore MH. Vancomycin-resistant enterococci in intensive care units: high frequency of stooI carriage during a non-outbreak period. Arch Intern Med. 1999;159:1467-1472.
36. Tokars JI, Satake S, Rimland D, et al. The prevalence of colonization with vancomycin-resistant Enterococcus at a Veterans' Affairs institution. Infect Control Hosp Epidemiol. 1999;20:171-175.
37. Kuehnert MJ, Jernigan JA, Pullen AL, Rimland D, Jarvis WR. Association between mucositis severity and vancomycin-resistant enterococcal bloodstream infection in hospitalized cancer patients. Infect Control Hosp EpidemioL 1999;20:660-663.
38. Fishbane S, Cunha BA, Mittal SK, Reggian J, Shea J, Sloch PE. Vancomycin-resistant enterococci in hemodialysis patients is related to intravenous vancomycin use. Infect Control Hosp Epidemiol. 1999;20:461-462.
39. Weber DJ, Rutala WA. Role of environmental contamination in the transmission of vamcomycin-resistant enterococci. Infect Control Hosp Epidemiol. 1997;18:306-309.
40. Wendt C, Wiesenthal B, Dietz E, Rüden H. Survival of vancomycin-resistant enterococci and vancomycin-susceptible enterococci on dry surfaces. J Clin Microbiol. 1998;36:3734-3736.
41. Neely AN, Maley MP. Survival of enterococci and staphylococci on hospital fabrics and plastic. J Clin Microbiol. 2000;38:724-726.
42. Noskin GA, Bednarz P, Suriano T, Reiner S, Peterson LR. Persistent contamination of fabric-covered furniture by vancomycin-resistant enterococci: implications for upholstery selection in hospitals. Am J Infect Control. 2000;28:311-313.
43. Carmeli Y, Samore H, Huskins WC. The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: a meta-analysis. Arch Intern Med. 1999;159:2461-2468.
44. McCabe WR, Jackson GG. Gram-negative bacteremia, I: etiology and ecology. Arch Intern Med. 1962;110:847-855.
45. Bone RC, Black RA, Cerra FB, et al. Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101:1644-1655.
46. Swenson JM, Clark NC, Ferraro MJ, et al. Development of a standarized screening method for detection of vancomycin-resistant enterococci. J Clin Microbiol. 1994;32:1700-1704.
47. Tenover FCM, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233-2239.
48. Livornese LL Jr, Dias S, Samel C, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med. 1992;117:112-116.
49. Porwancher R, Sheth A, Remphrey S, Taylor E, Hinkle C, Zervos M. Epidemiological study of hospital-acquired infection with vancomycin-resistant Enterococcus faecium: possible transmission by an electronic ear-probe thermometer. Infect Control Hosp Epidemiol. 1997;18:771-773.
50. Gould FK, Freeman R. Nosocomial infection with microsphere beds. Lancet. 1993;342:241-242.
51. Donskey CJ, Hanrahan JA, Hutton RA, Rice LB. Effect of parenteral antibiotic administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. J Infect Dis. 1999;180:384-390.
52. Donskey CJ, Chowdhry TK, Hecker MT, et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med. 2000;343:1925-1932.
53. Quale J, Landman D, Saurina G, Atwood E, DiTore V, Patel K. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis. 1996;23:1020-1025.
54. Bradley SJ, Wilson ALT, Allen MC, Sher HA, Goldstone AH, Scott GM. The control of hyperendimic glucopeptide-resistant Enterococcus spp on a haematology unit by changing antibiotic usage. J Antimicrob Chemother. 1999;43:261-266.
55. Donskey CJ, Hanrahan JA, Hutton RA, Rice LB. Effect of parenteral antbiotic administration on the establishment of colonization with vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. Clin Infect Dis. 2000;181:1830-1833.
56. D'Agata MC, Gautan S, Green WK, Tang Yi-Wei. High rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococci. Clin Infect Dis. 2002;34:167-172.